Option Therapeutics Inc.
CIK: 0002070577
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type other
State of Incorporation DE
Business Address 680 W NYE LN STE 201, CARSON CITY, NV, 89703
Mailing Address 680 W NYE LN STE 201, CARSON CITY, NV, 89703
Phone 775-446-0517
Fiscal Year End 0630
EIN 334884057
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-1 IPO registration statement | January 26, 2026 | View on SEC |
IPO Filings
S-1 January 26, 2026
- Specializes in innovative treatments for rare neurological disorders.
- Lead drug candidate, NeuroRestore, is in late-stage (Phase 2b/3) clinical trials for ALS.
Related Companies
Companies in the same industry (SIC: 2834)
Werewolf Therapeutics, Inc.
HOWL Pharmaceutical Preparations
Zenas BioPharma, Inc.
ZBIO Pharmaceutical Preparations
Centessa Pharmaceuticals plc
CNTA Pharmaceutical Preparations
Karyopharm Therapeutics Inc.
KPTI Pharmaceutical Preparations
VERTEX PHARMACEUTICALS INC / MA
VRTX Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.